Aminothiolester compounds and uses thereof

A compound of formula (I):

• in which:
• X is an atom chosen from O or S;
• R1 and R2 identical or different are independently chosen from:
• linear or branched (C1-C7)alkyl, linear or branched (C2-C7)alkenyl, aryl, heteroaryl, CHR5CHR6OR4 and (CHR5), OR4,
• said aryl and heteroaryl being optionally substituted by one or more substituents chosen from:
• linear or branched (C1-C7)alkyl, halogen, NO2 and CONH2;
• v is chosen from 2 to 4;
• R3 is chosen from linear or branched (C1-C7)alkyl, (C1-C7)alkyl —CO2Z and linear or branched (C1-C7)alkyl-NY1Y2;
• said linear or branched (C1-C7)alkyl-NY1Y2 being optionally substituted by (C1-C7)alkyl —CO2Z;
• R4 is chosen from:
• H, linear or branched (C2-C7)alkyl, linear or branched (C2-C7)alkenyl, —CONR7R8, aryl, heteroaryl, (C2-C7)cycloalkyl, linear or branched —(C1-C7)alkyl-aryl and linear or branched —(C1-C7)alkyl-heteroaryl;
• said aryl, (C2-C7)cycloalkyl, and heteroaryl being optionally substituted by one or more substituents chosen from:
• halogen, linear or branched (C1-C7)alkyl optionally substituted by one or more halogen atom, linear or branched (C1-C7)alkoxy optionally substituted by one or more halogen atom, —COOH, aryl, —NRR′, —NO2, or said aryl and heteroaryl being optionally fused to form an heterocycloalkyl;
• R5 and R6 identical or different are independently chosen from:
• H and linear or branched (C1-C7)alkyl, or
• R5 and R6 are linked together to form with the carbon atoms to which they are attached a cycloalkyl, aryl or heteroaryl, or
• R5 is H and R1 and R6 are linked together to form with the nitrogen atom linked to R1 an heterocycloalkyl or heteroaryl, or
• R6 is H and R1 and R5 are linked together to R1 to form with the nitrogen atom linked to R1 an heterocycloalkyl;
• R7 is —(C1-C3)alkyl;
• R8 is —(C1-C3)alkylNRR′;
• R and R′ identical or different, are independently chosen from H and linear or branched (C1-C7)alkyl,
• Y1 and Y2 identical or different are independently chosen from H and —CO—(C1-C7)alkyl;
• Z is chosen from H and linear or branched (C1-C7)alkyl;
• and in which, at least one of R1 and R2 is CHR5CHR6OR4 or (CHR5), OR4 when X is S and R3 is linear or branched (C1-C7)alkyl;
• or its pharmaceutically acceptable salts or optical isomers, racemates, diastereoisomers, enantiomers or tautomers.